Should I buy these 2 big-yielding FTSE 250 dividend stocks?

I’ve been searching for the best dividend stocks to buy on the FTSE 250. Do the gigantic yields on offer from these stocks make then unmissable?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m scouring the FTSE 250 for the best dividend stocks to buy this November. These two UK shares offer gigantic yields, sure. But are they a risk too far?

6.8% dividend yields

Financial product comparison website Moneysupermarket.com (LSE: MONY) had to bang its progressive dividend policy on the head in 2020 following the Covid-19 outbreak. But cheerily, City analysts are expecting shareholder payouts to start rising again from this year. This means the business sports massive yields of 5.8% and 6.8% for 2021 and 2022, respectively.

Trading at Moneysupermarket hasn’t been exactly rosy of late, however. Revenues tanked 10% in the three months to September, the withdrawal of energy tariffs by many suppliers smashing turnover at its home services division. Meanwhile sales at its insurance unit dropped as home and car insurance markets weakened. These divisions account for almost three-quarters of group income.

The question is, do Moneysupermarket’s massive yields still make it an attractive stock to buy? Not in my book, I’m afraid. Sure, it has arguably the strongest branding in its marketplace. This puts it in the box seat to exploit the growing product switching culture in Britain.

But I’m afraid that those recent headwinds could be set to persist, putting profits at Moneysupermarket (and by extension those huge yields) in serious danger. I’d rather buy other less-risky dividend shares today like Primary Health Properties (LSE: PHP).

In ruder health

Dividend yields here aren’t as impressive as those of Moneysupermarket. For 2021, this sits at 4%, and for 2022 at 4.2%. But this particular UK share has many of the qualities I seek in an income stock.

As the name suggests, this company owns and operates primary healthcare facilities like GP surgeries. Such properties remain in constant use at all points of the economic cycle, providing stable profits and reliable cash flows with which it can fund shareholder payouts. Indeed, Primary Health Properties raised the annual dividend 5.4% year-on-year (to 5.9p) in 2020 even as the Covid-19 crisis obliterated the broader economy.

Primary Health Properties has a long record of dividend growth behind it, too. It has lifted the annual reward for 24 years on the spin. And I think there’s good reason to expect profits and by extension dividends to keep climbing. Demand for healthcare services looks on course to grow and grow as Britain’s population steadily ages. Meanwhile, government policy intended to divert patients away from hospitals and to primary healthcare facilities also means companies like this are gaining increasing importance.

My only concern for Primary Healthcare Properties is that projected dividends for the next couple of years are barely covered by dividends. Coverage of 1 times sits way, way below the widely-regarded security benchmark of 2 times. Any earnings trouble could therefore cause dividends to fall short of forecasts.

That said, I believe the risk-to-reward outlook for this FTSE 250 share remains compelling. I think this is one of the best dividend stocks to buy right now for my portfolio.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Moneysupermarket.com and Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

What on earth’s going to happen to the BP share price in 2026?

Harvey Jones looks at how the BP share price is shaping up for the year ahead, and finds investors have…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Have a £20,000 lump sum? Here’s how to target a £8,667 yearly passive income

How to turn £20,000 into a £8,667 passive income? Our Foolish author explains one counterintuitive strategy to build such an…

Read more »

British coins and bank notes scattered on a surface
Dividend Shares

2 dividend stocks that yield double the current UK interest rate

Following the latest UK interest rate cut, Jon Smith points out a couple of options that offer generous income relative…

Read more »

Investing Articles

A 9% yield and now this! Check out the stunning Taylor Wimpey share price forecast for 2026

Harvey Jones has kept the faith in Taylor Wimpey shares despite a difficult run, bolstered by their incredible yield. Next…

Read more »

Investing Articles

How much do you need in an ISA to aim for a life-changing passive income of £30,000 a year?

Harvey Jones says ISA savers can transform their futures in 2026 by investing in FTSE 100 dividend stocks with huge…

Read more »

Investing Articles

My top 10 ISA and SIPP stocks in 2026

Find out why a FTSE 100 investment trust is now this writer's top holding across his Stocks and Shares ISA…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

£10,000 invested in Rolls-Royce shares 5 Christmases ago is now worth…

James Beard reflects on the post-pandemic Rolls-Royce share price rally and whether the group could become the UK’s most valuable…

Read more »

Investing Articles

Will Nvidia shares continue their epic run into 2026 and beyond?

Nvidia shares have an aura of invincibility as an AI boom continues to benefit the chipmaker. Can anything stop the…

Read more »